Catalina Valencia
President and Director, Director, 10% Owner · AXIM BIOTECHNOLOGIES, INC.
IndividualBuying only
- 2024
- Oct 15, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Catalina Valencia's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- TC Group VII S1, L.L.C. - $554.95M in MDLN purchases and sales in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M in DVA purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $430.69M in PBLS purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $399.66M in SYRE purchases and sales in the last 12 months
- Paul R. Vigano - $371.84M in AVAH purchases and sales in the last 12 months
- Robert M. Williams Jr. - $371.84M in AVAH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Catalina Valencia?
Catalina Valencia is a corporate insider, tracked as President and Director, Director, 10% Owner of AXIM BIOTECHNOLOGIES, INC. (AXIM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Catalina Valencia last file a Form 4?
The only primary Form 4 on record is dated 15 October 2024.
Has Catalina Valencia been buying or selling stock?
Recorded transactions: 1 open-market purchase and 0 open-market sales across all tracked filings.
